Head-to-head · WeighScore
Eloria vs June Health
The verdict
Eloria takes it — 65.4/100 to 62.7/100.
Eloria grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Eloria is a clinician-led GLP-1 weight-loss telehealth platform operated by Arora Health & Aesthetics.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Eloria | June Health |
|---|---|---|
| WeighScore | 65.4/100 | 62.7/100 |
| Grade | C | C |
| Scorecard rank | #224 | #269 |
| Semaglutide | $179/mo (starting dose, plus a separate fee, compounded) | $179/mo (starting dose, compounded) |
| Tirzepatide | Not disclosed | $179/mo (starting dose, compounded) |
| Coverage | Coverage not published | Coverage not published |
| Brand-name access | Yes | Compounded only |
| Oral / sublingual | Yes | Yes |
Graded #224 · C
Strengths
- Compounded GLP-1 injections from $179/mo and oral dissolving tablets from $249/mo, with no membership or hidden fees
- Also offers brand Wegovy (pill or injection) on a $99/mo membership plus medication cost
- Board-certified providers (via Arora Health & Aesthetics) and US-licensed pharmacies
- HSA/FSA accepted, free shipping on every order, and 24/7 support
- Full published compliance suite (Terms, Privacy, Refund, Shipping, Physician Code of Conduct, Consent to Telehealth)
Where it loses points
- Compounded medications are not FDA-approved - not brand Ozempic, Zepbound, or Mounjaro
- State availability varies and is not published - only where providers are licensed and pharmacies can dispense
- The compounding pharmacy partner is not named (US-licensed pharmacies only)
- No LegitScript certification displayed
- Brand Wegovy uses a separate $99/mo membership-plus-medication-cost model
Graded #269 · C
Strengths
- Offers both injectable and oral compounded semaglutide and tirzepatide
- Semaglutide starts at $179/mo (injectable) or $187/mo (tablets) — tirzepatide from $179/mo (injectable)
- Full per-dose price list published on-site with no signup required to view it
- Provider consult ('licensed clinician evaluation') is bundled into the displayed price
- Free discreet shipping advertised with 2-3 day delivery
Where it loses points
- No accessible Terms of Service or Privacy Policy — footer links go nowhere and standard URL guesses 404
- No LegitScript seal or other pharmacy-verification badge found anywhere on the site
- Legal entity, prescribing medical group, and compounding pharmacy partner are not named
- Domain was registered in May 2026 — a brand-new storefront with no independent reviews found
- Also sells 'MR-3' (retatrutide), a GLP-1/GIP/glucagon agonist with no FDA approval for any use
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.